GLO1 and amyotrophic lateral sclerosis: We observed less consistent results across disease groups for most of the remaining target-action pairs, including the lactoylglutathione lyase blocking medication, indomethacin, and targets of angiotensin-converting enzyme (chloroquine and hydroxychloroquine), which were not associated with ALS (Fig 1 and S2 Table in S1 File).